Tapewire

Nasdaq · USD

COLL

COLLEGIUM PHARMACEUTICAL, INC

Export transactions ↓
Tapewire entity
5169
SEC CIK
0001267565
Parsed reports
359

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 12, 2025 Filed Nov 14, 2025 21:13 UTC
Karnani VikramDirector · President and CEO
Tax withholdingCommon Stock 8,983 $47.35 $425,345.05
Disclosure

SEC source: 0001699488-25-000004 · form4-11142025_091156.xml · nonDerivative · entry 1

Karnani Vikram · CIK 0001699488 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,989

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units.

Read SEC document
November 06, 2025 Filed Nov 7, 2025 16:23 UTC
Tupper ColleenEVP & Chief Financial Officer
SaleCommon Stock 4,858 $41.28 $200,516.86
Disclosure

SEC source: 0001862082-25-000004 · form4-11072025_091106.xml · nonDerivative · entry 2

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 126,667

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.00 to $41.75, inclusive.

Read SEC document
November 06, 2025 Filed Nov 7, 2025 16:23 UTC
Tupper ColleenEVP & Chief Financial Officer
SaleCommon Stock 25,142 $40.38 $1,015,236.47
Disclosure

SEC source: 0001862082-25-000004 · form4-11072025_091106.xml · nonDerivative · entry 1

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 131,525

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
August 29, 2025 Filed Sep 3, 2025 20:56 UTC
Smith Thomas BEVP and Chief Medical Officer
SaleCommon Stock 17,478 $38.42 $671,576.42
Disclosure

SEC source: 0001062993-25-015277 · form4.xml · nonDerivative · entry 1

Smith Thomas B · CIK 0001748462 · EVP and Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,264

F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.37 to $38.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:57 UTC
Dreyer ScottEVP & Chief Commercial Officer
Exercise / conversionStock Option (Right to Purchase) · Derivative 16,389 $0.00 Strike: $21.34 $0.00
Disclosure

SEC source: 0001062993-25-014766 · form4.xml · derivative · entry 3

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,389 shares

Expires 2030-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:57 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 16,389 $38.21 $626,171.25
Disclosure

SEC source: 0001062993-25-014766 · form4.xml · nonDerivative · entry 2

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 103,613

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:57 UTC
Dreyer ScottEVP & Chief Commercial Officer
Exercise / conversionCommon Stock 16,389 $21.34 $349,741.26
Disclosure

SEC source: 0001062993-25-014766 · form4.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,002

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 21:10 UTC
SANTINI GINODirector
Exercise / conversionStock Option (Right to Purchase) · Derivative 15,000 $0.00 Strike: $13.45 $0.00
Disclosure

SEC source: 0001062993-25-014694 · form4.xml · derivative · entry 3

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2025-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 21:10 UTC
SANTINI GINODirector
SaleCommon Stock 5,405 $37.19 $201,018.44
Disclosure

SEC source: 0001062993-25-014694 · form4.xml · nonDerivative · entry 2

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,042

F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.17 to $37.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 21:10 UTC
SANTINI GINODirector
Exercise / conversionCommon Stock 15,000 $13.45 $201,750.00
Disclosure

SEC source: 0001062993-25-014694 · form4.xml · nonDerivative · entry 1

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,447

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 16:12 UTC SaleCommon Stock, par value $0.001 per share 25,000 $37.85 $946,250.00
Disclosure

SEC source: 0000902664-25-003729 · ownership.xml · nonDerivative · entry 1

Rubric Capital Management LP · CIK 0001687509 · 10% owner

Rosen David Efraim · CIK 0001898677 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 3,132,743

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.71 to $38.10, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F1 · ownership.nature: This Form 4 is filed by Rubric Capital Management LP ("Rubric Capital") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the "Rubric Vehicles"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital.

F2 · ownership.nature: The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 21:08 UTC
Dreyer ScottEVP & Chief Commercial Officer
Exercise / conversionStock Option (Right to Purchase) · Derivative 4,861 $0.00 Strike: $21.34 $0.00
Disclosure

SEC source: 0001062993-25-014526 · form4.xml · derivative · entry 3

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,389

Underlying: Common Stock · 4,861 shares

Expires 2030-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 21:08 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 4,861 $38.03 $184,880.84
Disclosure

SEC source: 0001062993-25-014526 · form4.xml · nonDerivative · entry 2

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 103,613

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 13, 2025 Filed Aug 15, 2025 21:08 UTC
Dreyer ScottEVP & Chief Commercial Officer
Exercise / conversionCommon Stock 4,861 $21.34 $103,733.74
Disclosure

SEC source: 0001062993-25-014526 · form4.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,474

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

Read SEC document
August 08, 2025 Filed Aug 12, 2025 21:18 UTC SaleCommon Stock 11,659 $34.36 $400,640.55
Disclosure

SEC source: 0001062993-25-014202 · form4.xml · nonDerivative · entry 1

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By: John Freund Family Partnership IV, L.P.

Disclosed balance after: 23,129

F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.27 to $34.535, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The Reporting Person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The Reporting Person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 21:04 UTC Exercise / conversionStock Option (Right to Purchase) · Derivative 15,000 $0.00 Strike: $13.45 $0.00
Disclosure

SEC source: 0001062993-25-011425 · form4.xml · derivative · entry 5

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2025-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 21:04 UTC SaleCommon Stock 6,601 $30.62 $202,149.02
Disclosure

SEC source: 0001062993-25-011425 · form4.xml · nonDerivative · entry 2

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,658

F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.62 to $30.628, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 21:04 UTC Exercise / conversionCommon Stock 15,000 $13.45 $201,750.00
Disclosure

SEC source: 0001062993-25-011425 · form4.xml · nonDerivative · entry 1

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:43 UTC
Lurker NancyDirector
GrantCommon Stock 9,791 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-009809 · form4.xml · nonDerivative · entry 1

Lurker Nancy · CIK 0001450485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,517

F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:42 UTC GrantCommon Stock 9,791 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-009806 · form4.xml · nonDerivative · entry 1

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,259

F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:39 UTC
SANTINI GINODirector
GrantCommon Stock 9,791 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-009805 · form4.xml · nonDerivative · entry 1

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,447

F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:42 UTC GrantCommon Stock 9,791 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-009808 · form4.xml · nonDerivative · entry 1

BOHLIN GAREN G · CIK 0001254705 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,259

F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:43 UTC GrantCommon Stock 9,791 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-009810 · form4.xml · nonDerivative · entry 1

Fallon John A. · CIK 0001560152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,634

F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:42 UTC GrantCommon Stock 9,791 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-009807 · form4.xml · nonDerivative · entry 1

Balice-Gordon Rita J. · CIK 0001825625 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,279

F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:37 UTC GrantCommon Stock 19,582 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-009804 · form4.xml · nonDerivative · entry 1

Paya Carlos V · CIK 0001606244 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,582

F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. 9,791 of the RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders; 9,791 of the RSUs vest on May 15, 2026, in each case subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.

Read SEC document
March 21, 2025 Filed Mar 24, 2025 17:06 UTC
Tupper ColleenEVP & Chief Financial Officer
SaleCommon Stock 6,396 $30.03 $192,068.68
Disclosure

SEC source: 0001062993-25-006149 · form4.xml · nonDerivative · entry 2

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,667

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.50, inclusive.

Read SEC document
March 21, 2025 Filed Mar 24, 2025 21:05 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 18,881 $30.03 $566,983.21
Disclosure

SEC source: 0001062993-25-006148 · form4.xml · nonDerivative · entry 2

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 103,613

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.48, inclusive.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 17:06 UTC
Tupper ColleenEVP & Chief Financial Officer
SaleCommon Stock 1,206 $30.00 $36,181.33
Disclosure

SEC source: 0001062993-25-006149 · form4.xml · nonDerivative · entry 1

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 163,063

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
March 20, 2025 Filed Mar 24, 2025 21:05 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 1,927 $30.00 $57,810.96
Disclosure

SEC source: 0001062993-25-006148 · form4.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 122,494

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
March 17, 2025 Filed Mar 19, 2025 20:36 UTC
Dieter DavidEVP & General Counsel
GrantCommon Stock 68,449 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-005904 · form4.xml · nonDerivative · entry 1

Dieter David · CIK 0002061438 · EVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,449

F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Thirty-three percent (33%) of the RSUs shall vest on March 17, 2026, with the balance vesting in two annual installments thereafter, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 17:35 UTC
Tupper ColleenEVP & Chief Financial Officer
SaleCommon Stock 977 $30.00 $29,313.32
Disclosure

SEC source: 0001062993-25-005753 · form4.xml · nonDerivative · entry 1

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,269

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).

Read SEC document
March 14, 2025 Filed Mar 18, 2025 21:34 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 2,255 $30.00 $67,661.05
Disclosure

SEC source: 0001062993-25-005752 · form4.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,421

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 16:49 UTC
Tupper ColleenEVP & Chief Financial Officer
SaleCommon Stock 10,445 $30.01 $313,412.67
Disclosure

SEC source: 0001062993-25-005395 · form4.xml · nonDerivative · entry 1

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,246

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).

Read SEC document
March 11, 2025 Filed Mar 18, 2025 23:18 UTC Amendment
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 15,387 $30.00 $461,671.55
Disclosure

SEC source: 0001062993-25-005834 · form4a.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 126,676

F1 · date: The original Form 4 filed on March 13, 2025 on behalf of the Reporting Person inadvertently reported the incorrect transaction date. As reported in this amendment, the correct transaction date is March 11, 2025.

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

Read SEC document
March 07, 2025 Filed Mar 10, 2025 16:02 UTC
Tupper ColleenEVP & Chief Financial Officer
SaleCommon Stock 1,504 $30.00 $45,121.05
Disclosure

SEC source: 0001062993-25-005021 · form4.xml · nonDerivative · entry 2

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,691

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).

Read SEC document
March 07, 2025 Filed Mar 10, 2025 20:01 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 2,348 $30.00 $70,445.87
Disclosure

SEC source: 0001062993-25-005020 · form4.xml · nonDerivative · entry 2

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,063

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive.

Read SEC document
March 06, 2025 Filed Mar 6, 2025 18:48 UTC
Kuhlmann Shirley R.EVP and General Counsel
SaleCommon Stock 26,067 $28.50 $742,945.99
Disclosure

SEC source: 0001062993-25-004776 · form4.xml · nonDerivative · entry 4

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,137

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.50 to $28.58, inclusive.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 16:02 UTC
Tupper ColleenEVP & Chief Financial Officer
SaleCommon Stock 1,949 $30.00 $58,470.00
Disclosure

SEC source: 0001062993-25-005021 · form4.xml · nonDerivative · entry 1

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,195

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024.

Read SEC document
March 06, 2025 Filed Mar 10, 2025 20:01 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 3,295 $30.00 $98,853.62
Disclosure

SEC source: 0001062993-25-005020 · form4.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 144,411

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
March 06, 2025 Filed Mar 13, 2025 20:50 UTC
Dreyer ScottEVP & Chief Commercial Officer
SaleCommon Stock 15,387 $30.00 $461,671.55
Disclosure

SEC source: 0001062993-25-005396 · form4.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 126,676

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

Read SEC document
March 05, 2025 Filed Mar 6, 2025 18:48 UTC
Kuhlmann Shirley R.EVP and General Counsel
SaleCommon Stock 20,000 $28.03 $560,528.00
Disclosure

SEC source: 0001062993-25-004776 · form4.xml · nonDerivative · entry 3

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,204

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.18, inclusive.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 18:48 UTC
Kuhlmann Shirley R.EVP and General Counsel
Exercise / conversionStock Option (Right to Purchase) · Derivative 40,000 $0.00 Strike: $24.03 $0.00
Disclosure

SEC source: 0001062993-25-004776 · form4.xml · derivative · entry 5

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2028-04-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 18:48 UTC
Kuhlmann Shirley R.EVP and General Counsel
SaleCommon Stock 40,000 $28.08 $1,123,160.00
Disclosure

SEC source: 0001062993-25-004776 · form4.xml · nonDerivative · entry 2

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,204

F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 18:48 UTC
Kuhlmann Shirley R.EVP and General Counsel
Exercise / conversionCommon Stock 40,000 $24.03 $961,200.00
Disclosure

SEC source: 0001062993-25-004776 · form4.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,204

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 16:10 UTC
Tupper ColleenEVP & Chief Financial Officer
Tax withholdingCommon Stock 22,317 $30.52 $681,114.84
Disclosure

SEC source: 0001062993-25-002178 · form4.xml · nonDerivative · entry 4

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,144

F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 16:10 UTC
Tupper ColleenEVP & Chief Financial Officer
Tax withholdingCommon Stock 8,109 $30.52 $247,486.68
Disclosure

SEC source: 0001062993-25-002178 · form4.xml · nonDerivative · entry 3

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,461

F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 16:10 UTC
Tupper ColleenEVP & Chief Financial Officer
GrantCommon Stock 26,957 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-002178 · form4.xml · nonDerivative · entry 2

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,570

F2 · shares: Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 26,957 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 16:10 UTC
Tupper ColleenEVP & Chief Financial Officer
GrantCommon Stock 51,768 $0.00 $0.00
Disclosure

SEC source: 0001062993-25-002178 · form4.xml · nonDerivative · entry 1

Tupper Colleen · CIK 0001862082 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,613

F1 · shares: Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 16:09 UTC
Kuhlmann Shirley R.EVP and General Counsel
Tax withholdingCommon Stock 25,149 $30.52 $767,547.48
Disclosure

SEC source: 0001062993-25-002175 · form4.xml · nonDerivative · entry 4

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,204

F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.

Read SEC document
February 10, 2025 Filed Feb 12, 2025 16:09 UTC
Kuhlmann Shirley R.EVP and General Counsel
Tax withholdingCommon Stock 9,826 $30.52 $299,889.52
Disclosure

SEC source: 0001062993-25-002175 · form4.xml · nonDerivative · entry 3

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,353

F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.